Home › Funds › Invesco Ltd › PCVX
Invesco Ltd position in PCVX
VAXCYTE INC · Health Care
Latest position (Q2 2026)173.44K sh
Reported value held$10.08M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 16.66K | $423.00K | New |
| Q4 2021 | 14.47K | $344.00K | Reduce |
| Q1 2022 | 27.19K | $656.00K | Add |
| Q2 2022 | 37.60K | $818.00K | Add |
| Q3 2022 | 36.05K | $864.00K | Reduce |
| Q4 2022 | 220.24K | $10.56M | Add |
| Q1 2023 | 39.47K | $1.48M | Reduce |
| Q2 2023 | 238.14K | $11.89M | Add |
| Q3 2023 | 151.56K | $7.73M | Reduce |
| Q4 2023 | 226.95K | $14.25M | Add |
| Q1 2024 | 1.23M | $84.33M | Add |
| Q2 2024 | 1.08M | $81.45M | Reduce |
| Q3 2024 | 1.31M | $149.93M | Add |
| Q4 2024 | 1.17M | $95.45M | Reduce |
| Q1 2025 | 1.26M | $47.42M | Add |
| Q2 2025 | 161.64K | $5.25M | Reduce |
| Q3 2025 | 179.08K | $6.45M | Add |
| Q4 2025 | 141.22K | $6.52M | Reduce |
| Q1 2026 | 184.04K | $10.69M | Add |
| Q2 2026 | 173.44K | $10.08M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PCVX
- Fidelity Management & Research (FMR) 20.85M sh · $1.21B · Q2 2026
- Janus Henderson Group 16.58M sh · $960.23M · Q1 2026
- BlackRock Inc 12.07M sh · $701.52M · Q2 2026
- Vanguard Group 12.19M sh · $562.63M · Q4 2025
- Wellington Management Group 7.00M sh · $407.00M · Q2 2026
- Geode Capital Management 3.46M sh · $201.13M · Q2 2026
- D. E. Shaw & Co 1.90M sh · $110.56M · Q2 2026
- Maverick Capital 1.61M sh · $93.78M · Q2 2026
- Charles Schwab Investment Management 1.46M sh · $85.15M · Q2 2026
- Goldman Sachs Group 1.38M sh · $79.98M · Q2 2026
- Northern Trust Corp 1.28M sh · $74.42M · Q2 2026
- Norges Bank Investment Management 1.25M sh · $72.42M · Q2 2026